Q32 Bio Inc.

NASDAQ: QTTB · Real-Time Price · USD
1.98
0.10 (5.32%)
At close: Aug 15, 2025, 3:59 PM
1.99
0.41%
After-hours: Aug 15, 2025, 07:01 PM EDT

Q32 Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a 1.86M 2.21M 3.02M 3.82M 2.76M 3.21M 3.21M 3.21M 4.08M 5.47M 33.97M 34.15M 33.04M 31.42M
Cost of Revenue
91K 121K 244K 244K 380K 823K 1.29M 1.92M 2.42M 2.64M 2.6M 4.36M 3.73M 2.94M 31.7M 30.29M 30.85M 31.42M
Gross Profit
-91K -121K -244K -244K 1.48M 1.39M 1.73M 1.9M 341K 567K 609K -1.15M 357K 2.53M 2.27M 3.86M 2.19M n/a
Operating Income
-54.74M -63.49M -66.1M -60.99M -66.54M -79.43M -92.1M -117.18M -125.68M -123.17M -133.28M -132.41M -130.21M -132.46M -95.95M -92.13M -89.74M -94.88M
Interest Income
2.8M 6.89M 6.19M 6.47M 6.69M 4.11M 5.58M 5.86M 5.7M 4.67M 3.23M 1.82M 601K 179K 185K 154K 142K 447K
Pretax Income
-52.28M -58.32M -46.09M -34.07M -46.06M -59.83M -87.08M -117.96M -119.98M -118.51M 1.2M 654K 1.64M -1.03M -95.76M -91.97M -89.6M -94.44M
Net Income
-52.3M -59.79M -47.73M -49.66M -65.02M -83.09M -112.96M -131.14M -131.91M -125.95M -5M -4.29M -1.18M -2.59M -95.76M -91.97M -89.6M -94.44M
Selling & General & Admin
17.47M 17.94M 17.84M 21.76M 24M 27.23M 29.97M 29.58M 30.05M 29.68M 35.54M 36.41M 35.19M 34.59M 27.29M 24.18M 24.42M 24.33M
Research & Development
37.18M 45.43M 48.14M 39.11M 42.28M 51.85M 62M 87.64M 95.97M 94.07M 98.35M 94.85M 92.98M 95.6M 93.08M 92.63M 89.06M 92.84M
Other Expenses
n/a n/a n/a n/a 84K 249K 249K 249K 165K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
54.65M 63.37M 65.98M 60.87M 66.28M 79.09M 91.97M 117.22M 126.02M 123.74M 133.89M 131.26M 128.17M 130.19M 120.38M 116.82M 113.48M 117.17M
Interest Expense
900K 2.3M 2M 2M 1.7M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -121K -121K -121K 4.39M 9.67M 15M 20.01M 15.5M 10.34M 5.01M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
54.74M 63.49M 66.1M 60.99M 66.54M 79.79M 93.26M 119.14M 128.44M 126.38M 136.49M 135.62M 134.29M 137.92M 129.92M 126.28M 122.78M 126.3M
Income Tax Expense
21K 1.47M -14.24M -14.27M -14.27M -15.71M n/a -101K -147K -252K 715K 816K 862K 967K n/a n/a n/a n/a
Shares Outstanding (Basic)
12.2M 12.2M 12.18M 12.08M 11.96M 3.21M 3.22M 3.21M 3.21M 3.21M 3.19M 3.19M 3.19M 3.18M 3.18M 3.17M 3.14M 2.8M
Shares Outstanding (Diluted)
12.2M 12.2M 12.18M 12.08M 11.96M 3.21M 3.22M 3.21M 3.21M 3.21M 3.19M 3.19M 3.19M 3.22M 3.18M 3.17M 3.14M 2.8M
EPS (Basic)
-5.47 -6.11 -5.12 -7.79 -16.58 -26.07 -35.16 -40.9 -41.22 -39.43 -1.49 -1.33 -0.41 -1.01 -30.33 -30.9 -32.49 -36.84
EPS (Diluted)
-4.3 -4.94 -3.95 -7.79 -16.58 -26.07 -35.16 -40.9 -41.22 -39.43 -1.78 -1.62 -0.7 -1.3 -30.33 -30.9 -32.49 -36.84
EBITDA
-31.69M -40.39M -44.5M -53.36M -58.9M -71.35M -83.56M -115.26M -123.26M -120.53M -130.68M -128.05M -124.09M -124.73M -86.37M -82.62M -80.35M -85.3M
EBIT
-32.15M -40.88M -44.99M -53.73M -42.72M -32.07M -24.6M -30.36M -54.15M -74.71M 26.33M 654K 1.64M -1.03M -95.76M -91.97M -89.6M -94.44M
Depreciation & Amortization
453K 483K 487K 410.81K 423.81K 866.81K 1.33M 1.92M 2.42M 2.64M 2.6M 4.36M 6.13M 7.73M 9.54M 9.46M 9.29M 9.13M